Free Trial

biote (BTMDW) Competitors

biote logo
$0.01 0.00 (-4.73%)
As of 07/23/2025

BTMDW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BCTXW, CALA, and CELUW

Should you be buying biote stock or one of its competitors? The main competitors of biote include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

biote vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and biote (NASDAQ:BTMDW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

In the previous week, 180 Life Sciences had 1 more articles in the media than biote. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for biote. 180 Life Sciences' average media sentiment score of 1.89 beat biote's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
biote Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
biote N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
biote$199.38MN/AN/AN/AN/A

Summary

180 Life Sciences beats biote on 2 of the 3 factors compared between the two stocks.

Get biote News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTMDW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTMDW vs. The Competition

MetricbioteMedicinal Chemicals IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$7.31B$2.18B$9.47B
Dividend YieldN/AN/A2.58%3.99%
P/E RatioN/AN/A22.1319.95
Price / SalesN/AN/A100.46101.76
Price / CashN/AN/A28.9258.97
Price / BookN/A759.0060.265.90
Net IncomeN/A-$4.30M-$121.56M$258.42M
7 Day PerformanceN/A4.69%0.79%2.12%
1 Month PerformanceN/A-30.14%2.53%12.46%
1 Year PerformanceN/AN/A25.52%19.56%

biote Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTMDW
biote
N/A$0.01
-4.7%
N/A-97.2%$0.00$199.38M0.00N/A
ATNFW
180 Life Sciences
N/A$0.01
-3.7%
N/A+11.8%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.16
-4.3%
N/AN/A$0.00$106.21K0.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$1.95
+6.0%
N/A-27.2%$0.00$585.60M0.004Positive News
Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
flat
N/AN/A$0.00$38.00M0.0070Positive News
Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.07
+1.6%
N/A-65.8%$0.00N/A0.008Gap Down
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.5%$0.00N/A0.0060
CELUW
Celularity
N/A$0.05
-6.4%
N/A+133.5%$0.00$54.22M0.00220Gap Down

Related Companies and Tools


This page (NASDAQ:BTMDW) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners